Long‑term exposure to leptin enhances the growth of prostate cancer cells

Noda,Terutaka; Kikugawa,Tadahiko; Tanji,Nozomu; Miura,Noriyoshi; Asai,Seiji; Higashiyama,Shigeki; Yokoyama,Masayoshi

doi:10.3892/ijo.2015.2845

Long‑term exposure to leptin enhances the growth of prostate cancer cells

Authors:
- Terutaka Noda
- Tadahiko Kikugawa
- Nozomu Tanji
- Noriyoshi Miura
- Seiji Asai
- Shigeki Higashiyama
- Masayoshi Yokoyama
View Affiliations

Affiliations: Department of Urology, Ehime University Graduate School of Medicine, Toon, Ehime 791‑0295, Japan, Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Ehime 791‑0295, Japan
Published online on: January 23, 2015 https://doi.org/10.3892/ijo.2015.2845
Pages: 1535-1542

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Obesity correlates with an increased risk of developing prostate cancer (PCa) and leptin plays an important role in PCa progression. Since leptin is produced by adipocytes, the serum leptin level is higher in obese than in non‑obese individuals. However, the effects of leptin remain controversial and unclear. The aim of the present study was to investigate the effect of leptin on PCa cell aggressiveness. Three human PCa cell lines (LNCaP, DU145 and PC‑3) were treated with recombinant leptin for 28 days. Cell proliferation, migration, and invasion were estimated using the WST assay, a wound‑healing assay, and a BD Matrigel invasion assay, respectively. The mechanism underlying the proliferative effect of leptin was investigated by cell transfections with small interfering RNA (siRNA) against the leptin receptor (ObR) or forkhead box O1 (FOXO1), and by immunocytochemistry. Long‑term exposure of PCa cells to leptin enhanced their proliferation, migration and invasion. Leptin increased ObR expression and enhanced Akt phosphorylation constitutively. Leptin also increased the phosphorylation of FOXO1 via PI3K signaling and FOXO1 gene silencing enhanced PCa cell proliferation. Leptin induced the translocation of FOXO1 from the nucleus to the cytoplasm. Furthermore, the PI3K inhibitor, LY294002 suppressed this translocation. These results suggested that leptin regulated the subcellular localization of FOXO1 and induced Akt phosphorylation. Additionally, we revealed that leptin increased the expression of cyclin D1 and decreased the expression of p21 protein. In conclusion, long‑term exposure to leptin increased the cell proliferation, migration, and invasion of PCa cells through inactivation of FOXO1. This inactivation resulted from exclusion of FOXO1 from the nucleus and its restriction to the cytoplasm through PI3K/Akt signaling. Our findings contribute to an understanding of the association between obesity and PCa aggressiveness.

View Figures

View References

1	Kaneko G, Miyajima A, Yuge K, Hasegawa M, Takeda T, Jinsaki M, Kikuchi E, Nakagawa K and Oya M: Periprostatic fat area is an independent factor that prolonged operative time in laparoscopic radical prostatectomy. Urology. 82:1304–1309. 2013. View Article : Google Scholar : PubMed/NCBI
2	Japanese Ministry of Health, Labour and Welfare. Results of Kokumin-Kenkou-Eiyou Chousa (in Japanese). http://www.mhlw.go.jp/.
3	Bray GA: The underlying basis for obesity: relationship to cancer. J Nutr. 132(Suppl 11): 3451S–3455S. 2002.PubMed/NCBI
4	Utada M, Ohno Y, Soda M and Kamo K: Estimation of cancer incidence in Japan with an age-period-cohort mode. Asian Pac J Cancer Prev. 11:1235–1240. 2010.
5	Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ and Willett WC: Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst. 95:1240–1244. 2003. View Article : Google Scholar : PubMed/NCBI
6	Andersson SO, Wolk A, Bergström R, Adami HO, Engholm G, Englund A and Nyrén O: Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst. 89:385–389. 1997. View Article : Google Scholar : PubMed/NCBI
7	Schuurman AG, Goldbohm RA, Dorant E and van den Brandt PA: Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol. 151:541–549. 2000. View Article : Google Scholar : PubMed/NCBI
8	Freedland SJ: Obesity and prostate cancer: a growing problem. Clin Cancer Res. 11:6763–6766. 2005. View Article : Google Scholar : PubMed/NCBI
9	Mistry AM, Swick AG and Romsos DR: Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice. J Nutr. 127:2065–2072. 1997.PubMed/NCBI
10	Liuzzi A, Savia G, Tagliaferri M, Lucantoni R, Berselli ME, Petroni ML, De Medici C and Viberti GC: Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord. 23:1066–1073. 1999. View Article : Google Scholar : PubMed/NCBI
11	Miller R, Tanofsky-Kraff M, Shomaker LB, et al: Serum leptin and loss of control eating in children and adolescents. Int J Obes (Lond). 38:397–403. 2014. View Article : Google Scholar
12	Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, et al: Biological action of leptin as an angiogenic factor. Science. 281:1683–1686. 1998. View Article : Google Scholar : PubMed/NCBI
13	Somasundar P, Yu AK, Vona-Davis L and McFadden DW: Differential effects of leptin on cancer in vitro. J Sur Res. 113:50–55. 2003. View Article : Google Scholar
14	Chang S, Hursting SD, Contois JH, et al: Leptin and prostate cancer. Prostate. 46:62–67. 2001. View Article : Google Scholar : PubMed/NCBI
15	Tewari R, Rajender S, Natu SM, Goel A, Dalela D, Goel MM and Tondon P: Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men - a cross-sectional study. Cytokine. 63:130–134. 2013. View Article : Google Scholar : PubMed/NCBI
16	Hoon Kim J, Lee SY, Myung SC, Kim YS, Kim TH and Kim MK: Clinical significance of the leptin and leptin receptor expressions in prostate tissues. Asian J Androl. 10:923–928. 2008. View Article : Google Scholar
17	Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ and Peppelenbosch MP: Leptin is a growth factor for colonic epithelial cells. Gastroenterology. 121:79–90. 2001. View Article : Google Scholar : PubMed/NCBI
18	Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D and Barrett KE: Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg. 94:346–354. 2007. View Article : Google Scholar : PubMed/NCBI
19	Somasundar P, Frankenberry KA, Skinner H, et al: Prostate cancer cell proliferation is influenced by leptin. J Surg Res. 118:71–82. 2004. View Article : Google Scholar : PubMed/NCBI
20	Hoda MR and Popken G: Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells. BJU Int. 102:383–388. 2008. View Article : Google Scholar : PubMed/NCBI
21	Onuma M, Bub JD, Rummel TL and Iwamoto Y: Prostate cancer cell-adipocyte interation: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem. 278:42660–42667. 2003. View Article : Google Scholar : PubMed/NCBI
22	Deo DD, Rao AP, Bose SS, et al: Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells. J Biomed Biotechnol. 2008:1639022008. View Article : Google Scholar : PubMed/NCBI
23	Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR and Heston WD: Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst. 87:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
24	Park SH, Chang SN, Baek MW, Kim DJ, Na YR, Seok SH, Lee BH, Kim KS and Park JH: Effects of dietary high fat on prostate intraepithelial neoplasia in TRAMP mice. Lab Anim Res. 29:39–47. 2013. View Article : Google Scholar : PubMed/NCBI
25	Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S and Surmacz E: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar : PubMed/NCBI
26	Ishikawa M, Kitayama J and Nagawa H: Expression pattern of leptin and leptin receptor (OB-R) in human gastric cancer. World J Gastroenterol. 12:5517–5522. 2006.PubMed/NCBI
27	Riolfi M, Ferla R, Del Valle L, et al: Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy. Brain Pathol. 20:481–489. 2010. View Article : Google Scholar :
28	Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP and Reynolds JV: Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg. 97:1020–2027. 2010. View Article : Google Scholar : PubMed/NCBI
29	Zhang X, Tang N, Hadden TJ and Rishi AK: Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 1813:1978–1986. 2011. View Article : Google Scholar : PubMed/NCBI
30	Huang H and Tindall DJ: Dynamic FoxO transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
31	Li R, Erdamar S, Dai H, Wheeler TM, Frolov A, Scardino PT, Thompson TC and Ayala GE: Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer. Hum Pathol. 38:1501–1507. 2007. View Article : Google Scholar : PubMed/NCBI
32	Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, Jensen ED, Westendorf JJ, Cheng L and Huang H: FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res. 71:3257–3267. 2011. View Article : Google Scholar : PubMed/NCBI
33	Zhang H, Fang J, Yao D, Wu Y, Ip C and Dong Y: Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells. Prostate. 70:1265–1273. 2010.PubMed/NCBI
34	Scodelaro Bilbao P and Boland R: Extracellular ATP regulates FoxO family of transcription factors and cell cycle progression through PI3K/Akt in MCF-7 cells. Biochim Biophys Acta. 1830:4456–4469. 2013. View Article : Google Scholar : PubMed/NCBI
35	Berry E, Hardt JL, Clardy J, Lurain JR and Kim JJ: Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1. Gynecol Oncol. 112:331–336. 2009. View Article : Google Scholar :
36	Rena G, Guo S, Cichy SC, Unterman TG and Cohen P: Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem. 274:17179–17183. 1999. View Article : Google Scholar : PubMed/NCBI
37	Kau TR, Schroeder F, Ramaswamy S, Wojciechowski CL, Zhao JJ, Roberts TM, Clardy J, Sellers WR and Silver PA: A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell. 4:463–476. 2003. View Article : Google Scholar
38	Wen Q, Duan X, Liao R, Little P, Gao G, Jiang H, Lalit S, Quirion R and Zheng W: Characterization of intracellular translocation of Forkhead transcription factor O (FoxO) members induced by NGF in PC12 cells. Neurosci Lett. 498:31–36. 2011. View Article : Google Scholar : PubMed/NCBI
39	Wu Z, Sun H, Zeng W, He J and Mao X: Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS One. 7:e458252012. View Article : Google Scholar : PubMed/NCBI
40	Chen Q, Ganapathy S, Singh KP, Shankar S and Srivastava RK: Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One. 5:e152882010. View Article : Google Scholar : PubMed/NCBI
41	Lee SH, Kang YJ, Sung B, et al: MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells. Int J Oncol. 44:905–911. 2014.PubMed/NCBI
42	Liu P, Li S, Gan L, Kao TP and Huang H: A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells. Cancer Res. 68:10290–10299. 2008. View Article : Google Scholar : PubMed/NCBI